-

10:31:19 PM

LHDX Stock News

LHDX - Lucira Health Inc

10/12/21 7:00 AM

Nasdaq : LHDX

covid-19

LUCIRA™ HEALTH COVID-19 Test Approved for Sale in Singapore

Singapore Health Sciences Authority issues approval by its Pandemic Special Access Route (PSAR) for the LUCIRA CHECK IT COVID-19 Test Kit. Lucira has partnered with Labgistics Asia Pte Ltd for the importation and distribution of its products in Singapore. EMERYVILLE, Calif., Oct. 12, 2021 (GLOBE

RHEA-AI

very positive

10/08/21 6:00 AM

Nasdaq : LHDX

LUCIRA™ HEALTH Provides Statement on Copan’s Recall of its FLOQSwabs

Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today commented on the recent recall

RHEA-AI

neutral

09/20/21 4:01 PM

Nasdaq : LHDX

management

LUCIRA™ HEALTH Hires Tony Allen as Chief Operations Officer

Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative

RHEA-AI

neutral

08/23/21 6:00 AM

Nasdaq : LHDX

management

LUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory Affairs

Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced life science professional Ghazi Kashmolah has joined the company as Chief

RHEA-AI

very positive

08/12/21 4:01 PM

Nasdaq : LHDX

earnings

Lucira Health Announces Second Quarter 2021 Financial Results

Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported

RHEA-AI

neutral

07/29/21 7:00 AM

Nasdaq : LHDX

earnings

Lucira Health to Announce Second Quarter 2021 Financial Results

Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report second

RHEA-AI

neutral

05/28/21 6:00 AM

Nasdaq : LHDX

management

LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin Collins

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced medtech veteran Kevin Collins has joined the company as Chief Revenue Officer with global revenue

RHEA-AI

neutral

05/25/21 7:00 AM

Nasdaq : LHDX

conferences

Lucira Health to Participate in William Blair 41st Annual Growth Stock Conference

Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will

RHEA-AI

neutral

05/13/21 4:01 PM

Nasdaq : LHDX

earnings

Lucira Health Announces First Quarter 2021 Financial Results

Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported

RHEA-AI

neutral

05/12/21 6:00 AM

Nasdaq : LHDX

covid-19

LUCIRA™ CHECK IT COVID-19 Self-Test Now Available on Amazon

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that its LUCIRA™ CHECK IT COVID-19 test kit is now available on Amazon.com in the US. Each LUCIRA CHECK IT

RHEA-AI

neutral

LHDX Data:

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.lucirahealth.com
Security nameLucira Health Inc
Issue typecs
SectorManufacturing
Sic code2835
Employees57

LHDX Description:

Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA COVID19 All-In-One Test Kit is designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.